These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of radiosensitizing drugs in the management of cancer. Adams GE Invest Cell Pathol; 1979; 2(4):303-8. PubMed ID: 396284 [TBL] [Abstract][Full Text] [Related]
3. Chemical radiosensitizers for use in radiotherapy. Wardman P Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086 [TBL] [Abstract][Full Text] [Related]
4. [Cancer and radiotherapy(3). Radiobiology for radiotherapy]. Ando K Iyodenshi To Seitai Kogaku; 1982 Apr; 20(2):122-9. PubMed ID: 6752496 [No Abstract] [Full Text] [Related]
5. [Theoretical bases for using modifying agents in the radiation therapy of malignant neoplasms (the Modifier program)]. Kuzin AM; Tsyb AF; Iarmonenko SP; Pelevina II; Konopliannikov AG Radiobiologiia; 1981; 21(5):744-51. PubMed ID: 7031758 [No Abstract] [Full Text] [Related]
6. The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments. Hoogsteen IJ; Marres HA; van der Kogel AJ; Kaanders JH Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):385-96. PubMed ID: 17433637 [TBL] [Abstract][Full Text] [Related]
7. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide. Saunders M; Dische S Br J Cancer Suppl; 1996 Jul; 27():S271-8. PubMed ID: 8763896 [TBL] [Abstract][Full Text] [Related]
8. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Sun JR; Brown JM Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067 [TBL] [Abstract][Full Text] [Related]
9. The potential for improving radiotherapy outcome by improving the oxygen supply to solid tumours. Denekamp J; Waites A Strahlenther Onkol; 1996 Nov; 172 Suppl 2():22-3. PubMed ID: 8946041 [No Abstract] [Full Text] [Related]
12. Early skin response to fractionated doses of pions for determining therapeutic gain factors. Ohizumi Y; Lam GK; Pickles T; Chaplin DJ Tokai J Exp Clin Med; 1996 Jun; 21(2):69-75. PubMed ID: 9239808 [TBL] [Abstract][Full Text] [Related]
13. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers. Shi M; Guo XT; Shu MG; Chen FL; Li LW Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792 [TBL] [Abstract][Full Text] [Related]
14. Importance of hypoxic cells to radiation treatment: further considerations. Suit HD Cancer J Sci Am; 1999; 5(6):334-5. PubMed ID: 10606472 [No Abstract] [Full Text] [Related]
15. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway. De Ridder M; Van Esch G; Engels B; Verovski V; Storme G Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408 [TBL] [Abstract][Full Text] [Related]
16. [Radiation sensitizing agents for hypoxic cells: past, present and future]. Lartigau E Cancer Radiother; 1998 Dec; 2(6):775-80. PubMed ID: 9922787 [TBL] [Abstract][Full Text] [Related]
17. Radiosensitization of hypoxic cells by chemical drugs. Singhal NC; Sharma NC; Udawat JP Indian J Cancer; 1977 Sep; 14(3):269-71. PubMed ID: 924510 [No Abstract] [Full Text] [Related]
18. Radiosensitizers: rationale and potential. Brown JM Cancer Treat Rep; 1981; 65 Suppl 2():95-102. PubMed ID: 7346152 [TBL] [Abstract][Full Text] [Related]
19. Current aspects of radiobiology as applied to radiotherapy. Fowler JF Clin Radiol; 1972 Jul; 23(3):257-62. PubMed ID: 5046526 [No Abstract] [Full Text] [Related]
20. Hyperbaric oxygen as an adjunct to radiation therapy. Lindberg R Tex Med; 1970 Aug; 66(8):54-7. PubMed ID: 5451530 [No Abstract] [Full Text] [Related] [Next] [New Search]